A TEAM of scientists, including
researchers at the University of
Western Australia, say that the
illicit drug ecstasy may be able to
play a cancer-fighting role at some
stage in the future.
A report in the Investigational
New Drugs journal details how they
have re-engineered ecstasy, with
one of the variants increasing the
drug’s cancer-fighting effectiveness
by more than 100 times.The above article was sent to subscribers in Pharmacy Daily's issue from 23 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Aug 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.